New uses for aspirin … and other research

Ann Robinson reviews the latest research on the use of aspirin in treating metabolic dysfunction-associated steatotic liver disease. A preliminary study found that taking a low dose of aspirin for six months reduced hepatic fat quantity significantly. However, further research with a larger sample size is needed. In another study, text message and patient portal reminders did not significantly increase flu vaccination rates. Repeat messaging also did not lead to improved clinical outcomes in a study on flu vaccine uptake. Additionally, a study on pregnant women with epilepsy found that certain antiseizure drugs may increase the risk of autism in children. Finally, a global study found that the prevalence of underweight and obesity has increased in most countries, highlighting the importance of access to nutritious foods.

Source link

error: Content is protected !!